Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • Wednesday
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential AssessmentBusiness Wire • 10/22/26
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine DevelopmentBusiness Wire • 10/13/26
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference CallBusiness Wire • 10/09/26
Charles River and Autolomous Partner to Transform Laboratory Execution SystemsBusiness Wire • 10/06/26
Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day TranscriptSeeking Alpha • 09/24/26
Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On ThursdayBenzinga • 09/24/26
Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor DayBusiness Wire • 09/24/26
Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking TimelinesBusiness Wire • 09/17/26
Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Charles River Laboratories to Present at Morgan Stanley and Baird ConferencesBusiness Wire • 09/11/26
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production SuiteBusiness Wire • 09/08/26
Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/04/26
22 best-performing stocks of August, as the software industry continues its recoveryMarket Watch • 08/31/26
Wall Street Is Now Backing the Clarity Act. Here's the Most Likely Scenario for What Happens Next With Crypto.The Motley Fool • 08/27/26
CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?Zacks Investment Research • 08/21/26